Organoid Culture: The potential to revolutionize disease modeling
Organoids have emerged as a revolutionary tool in drug discovery and clinical practice. These miniature 3D structures, cultivated from stem cells or differentiated cells, mimic the architecture and function of organs, offering a significant advancement over...
New Location!
Scinus Cell Expansion is moving to Zeist As of June 1st, Scinus Cell Expansion will be located at the Utrecht Science Park location in Zeist! This place provides a vibrant, dynamic and exciting place to work, where industry and academia come together. Feel free to...
Ask the Expert: Process Development Engineer Juda-El Sam on iPSC culture using the SCINUS bioreactor NG
To standardize iPSC differentiation and production to a level necessary for producing therapy grade cells, Process Development Engineer Juda-El Sam from Scinus Cell Expansion is working on developing protocols for iPSC expansion using the SCINUS bioreactor NG. โAt the...
iPSCs for personalized cell therapy: prospects and remaining challenges
The unique nature of induced pluripotent stem cells (iPSCs) lies in their capability for unlimited selfโrenewal and programmed differentiation into virtually any adult cell types [1]. iPSC based technology holds the potential to treat a multitude of diseases and...
Scinus recognized as one of the Top Cell Therapy Companies In Europe by Life Sciences Review
SCINUS simplifies operational procedures and significantly diminishes the overall cost of ownership.
The Potential of AI in Cell Therapy and bioreactor systems.
Bioprocess control and continuous process improvement are crucial for the evolving field of cell therapy development and bioreactors. Combination of the current control and optimization technologies with the latest computer-based strategies will accelerate the path...
Exploring the Promise of Mesenchymal Stromal Cells (MSCs) in Cell Therapy
A versatile and promising cell type in the field of regenerative medicineMesenchymal stromal cells (MSCs) have emerged as a versatile and promising tool in the field of regenerative medicine, offering a multitude of therapeutic possibilities. These multipotent cells...
Our Carboxygenator in the spotlight!
Ever wondered how our carboxygenator precisely works within the SCINUS bioreactor NG? We get that question more often, so today we're excited to share the science behind it, step by step: ๐ฃ๐ฟ๐ฒ๐ฐ๐ถ๐๐ฒ ๐๐ฎ๐ ๐๐ผ๐ป๐๐ฟ๐ผ๐น: The carboxygenator is a patented oxygenation system that's...
Press release – Dutch-Danish collaboration on cell therapy
Developing an efficient cell therapy production platform togetherPRESS RELEASE Bilthoven (NL)/Aarhus (DK), July 2023 Dutch-Danish collaboration on cell therapy Cell therapy, which uses cultured human cells, is a promising treatment option for a wide range of diseases....
Scinus wins PRIX GALIEN medtech innovation AWARD 2022
Scinus wins PRIX GALIEN medtech innovation AWARD. At the 28th presentation of the Prix Galien Nederland Awards 2022, the Prix Galien MedTech Innovation Award was presented for the 4th time. Scinus Cell Expansion - a Demcon Investment company - received the MedTech...